Randall Hogan, Chairman, CEO Total compensation: $4,979,305 for the year ended Dec. 31, 2008
Salary: $1,003,600
Non-equity incentive pay: $525,155
Other compensation: $203,771
Exercised stock options: $770,325
Value realized on vesting shares: $2,476,454
New stock options: 333,250
Total return to shareholders: 30.5 percent
Note: Hogan's total compensation was down from $10. 5 million last year, mainly due to fewer gains from the exercise of stock options and a lower bonus. The company's compensation committee also changed the 2009 compensation mix for named executives. Salaries will be frozen at 2008 levels, and long-term incentive pay was redone to reduce the equity-based portion of long-term incentive compensation.
PATRICK KENNEDY
The late Dr. David Ahlquist co-invented ColoGuard, which is helping drive Abbott Laboratories’ acquisition of Exact Sciences. After an ALS diagnosis in 2019, Ahlquist wasn’t done inventing.
